Literature DB >> 11835534

Variability in molecular typing of Coxsackie A viruses by RFLP analysis and sequencing.

Nikolaos Siafakas1, Panayotis Markoulatos, Glyn Stanway.   

Abstract

The aim of the present study was to develop an assay capable of classifying the Coxsackie A virus (CAV) prototype strains on the basis of restriction fragment length polymorphism (RFLP) analysis of 5'-UTR-derived reverse transcription polymerase chain reaction (RT-PCR) amplicons, and to determine how these data could be used for typing wild-type CAV isolates. Moreover, sequencing of the amplified genomic fragments of the clinical isolates, and comparison with all the published sequences of the respective genomic region of enterovirus reference and wild-type strains were attempted for typing of the isolates. Twenty-four prototype CAV strains from the 23 currently recognized serotypes were studied; most of them were successfully differentiated with the aid of four restriction endonucleases: HaeIII, HpaII, DdeI, and StyI. It was not possible to differentiate between CAV5, 7, and 16, or between CAV15 and 18 in this way, but the members of each of these two groups were satisfactorily differentiated with the aid of single-strand conformational polymorphism (SSCP) analysis of their RT-PCR amplicons. Fifteen clinical isolates, 13 of them of known CAV serotype, were also studied with the same four endonucleases and the results were compared with the data obtained from the RFLP analysis of the reference strains. The experimental results showed that only two clinical samples of previously known identity had an identical restriction pattern with the respective prototype strains. The sequences of the amplicons of the clinical isolates had the greatest percentage of alignment with enterovirus strains of a different serotype, indicating variability in the 5'-UTR and the inability to use the whole sequence of the amplicons for typing CAVs. The significance of the findings in relation to the possible usefulness of the RFLP-based method is discussed. Copyright 2002 Wiley‐Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11835534      PMCID: PMC6807804          DOI: 10.1002/jcla.2063

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  25 in total

1.  The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay.

Authors:  J Balanant; S Guillot; A Candrea; F Delpeyroux; R Crainic
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

2.  Detection and rapid differentiation of human enteroviruses following genomic amplification.

Authors:  M M Kuan
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Molecular comparison of coxsackie A virus serotypes.

Authors:  T Pulli; P Koskimies; T Hyypiä
Journal:  Virology       Date:  1995-09-10       Impact factor: 3.616

4.  Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay.

Authors:  S L Klespies; D E Cebula; C L Kelley; D Galehouse; C C Maurer
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

Review 5.  Classification of enteroviruses based on molecular and biological properties.

Authors:  T Hyypiä; T Hovi; N J Knowles; G Stanway
Journal:  J Gen Virol       Date:  1997-01       Impact factor: 3.891

6.  Isolation of polioviruses and other enteroviruses in south Greece between 1994 and 1998.

Authors:  N Siafakas; A Georgopoulou; P Markoulatos; N Spyrou
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 7.  Biology of coxsackie A viruses.

Authors:  T Hyypiä; G Stanway
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

8.  Evolutionary study on the Coxsackievirus A 24 variant causing acute hemorrhagic conjunctivitis by oligonucleotide mapping analysis of RNA genome.

Authors:  K Miyamura; N Takeda; M Tanimura; T Ogino; S Yamazaki; C W Chen; K H Lin; S Y Lin; A Ghafoor; M Yin-Murphy
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

9.  Rapid subgrouping of nonpolio enterovirus associated with Aseptic Meningitis by RFLP (Restriction Fragment Length Polymorphism) assay.

Authors:  Y T Jung; G R Kim; S R Lee; S Y Paik
Journal:  Mol Cells       Date:  1998-06-30       Impact factor: 5.034

10.  Enzyme-linked immunosorbent assay for detection and identification of coxsackieviruses A.

Authors:  R H Yolken; V M Torsch
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

View more
  3 in total

1.  Enteroviral infection in Greek AIDS patients.

Authors:  Dimitrios Papaventsis; Panayotis Markoulatos; Nikolaos Mangafas; Marios Lazanas; Stamatina Levidiotou-Stefanou
Journal:  Mol Diagn       Date:  2004

2.  Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes.

Authors:  M Steven Oberste; Kaija Maher; Mark A Pallansch
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors.

Authors:  Wei Zhang; Haishi Qiao; Yuanzi Lv; Jingjing Wang; Xiaoqing Chen; Yayi Hou; Renxiang Tan; Erguang Li
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.